ArticleAnatomical record (Hoboken, N.J. : 2007)2026
Evaluation of IHH, PTCH1, and SMO protein immunohistochemistry in the human mandibular condyle at fetal stages from 30 to 80 mm greatest length.
Article in Anatomical record (Hoboken, N.J. : 2007), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study evaluated the morphogenesis of the temporomandibular joint (TMJ) in human fetuses during the third month of gestation through the analysis of immunohistochemistry for the proteins Indian Hedgehog (IHH), Patched-1 (PTCH1), and Smoothened (SMO). These proteins are critical components of the Hedgehog signaling pathway in the embryonic development. Together, they transduce essential intracellular signals for cartilage and bone development and regulate chondrocyte differentiation and growth as part of the synergistic molecular mechanisms that converge to form synovial joints, including the TMJ. A prospective observational study was conducted on six human fetuses at fetal stages ranging from 30 to 80 mm greatest length (estimated to range between 9 and 12 weeks gestational age). Hematoxylin-eosin staining was used for morphological analysis, and protein immunostaining was assessed through immunohistochemistry. The percentage of immunostaining was quantified using digital image analysis with ImageJ software. IHH immunostaining peaked at the 30 mm stage (4.63%), decreased at 60 mm (2.16%), increased at 70 mm (3.70%), and declined again at 80 mm (2.75%). PTCH1 showed the highest immunostaining at 30 mm (5.35%), with a progressive decrease to its lowest level at 80 mm (1.18%). SMO immunostaining was highest at 30 mm (4.07%), decreased at 60 mm (1.80%), and increased at 70 mm (2.63%) and 80 mm (3.52%). Strong correlations were found between IHH and PTCH1 (rho = 0.70) and between IHH and SMO (rho = 0.70), while PTCH1 and SMO showed a moderate correlation (rho = -0.30). These findings highlight the dynamic protein activity and their critical roles in TMJ morphogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.